logo

ACRS

Aclaris TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ACRS Profile

Aclaris Therapeutics, Inc.

A clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases

Pharmaceutical
--
10/07/2015
NASDAQ Stock Exchange
61
12-31
Common stock
701 Lee Road, Suite 103, Wayne, PA 19087
--
Aclaris Therapeutics, Inc., was founded in July 2012 in Delaware, USA. The company is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immune inflammatory diseases.